СРАВНИТЕЛЬНЫЙ АНАЛИЗ ПРОФИЛАКТИЧЕСКОГО ОСТЕОПРОТЕКТИВНОГО СВОЙСТВА L-АРГИНИНА И КАЛЬЦИЯ Д3 ПРИ ЭКСПЕРИМЕНТАЛЬНОМ ГИПОЭСТРОГЕННОМ ОСТЕОПОРОЗЕ
Список литературы
Benevolenskaya L.I Osteoporosis the problem of osteoporosis in modern medicine // Rheumatology. 2005. – Т. 7. – № 8.
Galagan M.E, Shirokolova A.V, Vanin.A.F, Hypotensive effects of nitric oxide produced from exogenous and endogenous sources // Questions of medical chemistry (Вопр. мед. Химии) – 1991. – Т. 37. – № 1. – page. 67-70.
Gudyrev D.C, Osteoprotective effect of enalapril and losartan in experimental osteoporosis and fractures on its background. Ph.D. dissertation of medical Sciences (14.00.25) // Kursk. KSMU. – Kursk. – 2008. – page 22.
Nasonov E.L, Secondary osteoporosis: pathogenesis and clinical significance in inflammatory diseases of the joints // Osteoporosis and osteopathy. – 1998. – № 3. – page 18-20.
Rozhen L.Y, Systemic osteoporosis, A Practical Guide for Physicians. // Publisher Mokeev. – 2000. – С. 195.
Alagiakrishnan K., Juby A., Hanley D/ et al.Role of vascular factors in osteoporosis // J. Gerontol. A Biol. Sci. Med. Sci. – 2003. – Vol. 58. – P. 362-366.
Laursen J.B., Rajagopalan S., Galis Z. et all. Of superoxide in angiotensin IIinduced but catecholamineinduced hypertension / Circulation. 1997. Vol. 95. P. 588-593.
Stimpel M., Jee W.S., Ma Y. et al. Impact of antihypertensive therapy on postmenopausal osteoporosis: effects of the angiotensin converting enzyme inhibitor moexipril, 17betaestradiol and their combination on the ovariectomyinduced cancellous bone loss in young rats // J. Hypertens. – 1995. – Vol. 13. – P. 1852-1856.